Bruno Hancock
5Patents
3h-index
16Co-inventors
46Inventor score
Filing activity: Mar 8, 1999 → Oct 30, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7235260B2 | Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor | Human Necessities | 17 | Expired |
| US9211261B2 | Immediate release dosage forms containing solid drug dispersions | Human Necessities | 13 | Active |
| US6063811A | Compositions for a once day treatment of cyclooxygenase-2 mediated diseases | Human Necessities | 11 | Expired |
| US8828438B2 | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase | Human Necessities | 2 | Active |
| US7897175B2 | Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.